{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:14:04Z","timestamp":1774991644170,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.cld.2008.02.005","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T10:00:23Z","timestamp":1210327223000},"page":"407-424","source":"Crossref","is-referenced-by-count":51,"title":["Osteoporosis in Primary Biliary Cirrhosis: Pathogenesis and Treatment"],"prefix":"10.1016","volume":"12","author":[{"given":"Albert","family":"Par\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Gua\u00f1abens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2008.02.005_bib1","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2008.02.005_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(77)92167-5","article-title":"Intestinal absorption of 25\u2014hydroxyvitamin D and osteomalacia in primary biliary cirrhosis","volume":"1","author":"Compston","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.005_bib3","first-page":"82","article-title":"Las manifestaciones osteoarticulares en la cirrosis biliar primaria","volume":"6","author":"Branc\u00f3s","year":"1979","journal-title":"Rev Esp Reumatol"},{"key":"10.1016\/j.cld.2008.02.005_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0016-5085(82)80299-0","article-title":"25\u2014Hydroxyvitamin D3 treatment of bone disease in primary biliary cirrhosis","volume":"83","author":"Arnaud","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.005_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","article-title":"Osteoporosis in primary biliary cirrhosis: effects of 25\u2014hydroxyvitamin D3 treatment","volume":"83","author":"Matloff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840040101","article-title":"Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia","volume":"4","author":"Cuthbert","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0016-5085(82)80292-8","article-title":"Bone disease in primary biliary cirrhosis: histologic features and response to 25\u2014hydroxyvitamin D","volume":"83","author":"Herlong","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.005_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","article-title":"Bone loss and reduced osteoblast function in primary biliary cirrhosis","volume":"103","author":"Hodgson","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2008.02.005_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.1840070127","article-title":"Low bone turnover state in primary biliary cirrhosis","volume":"7","author":"Stellon","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double\u2014blind, controlled 1\u2014year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib11","first-page":"1356","article-title":"Factors influencing the development of metabolic bone disease in primary biliary cirrhosis","volume":"85","author":"Gua\u00f1abens","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.005_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis","volume":"14","author":"Eastell","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Guanabens","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(94)80132-0","article-title":"Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis","volume":"21","author":"Gua\u00f1abens","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib16","first-page":"389","article-title":"Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?","volume":"21","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00042737-199903000-00018","article-title":"Noninvasive assessment of bone density in primary biliary cirrhosis","volume":"11","author":"Pereira","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","article-title":"Vitamin-D receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis","volume":"118","author":"Springer","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.005_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/gut.49.2.282","article-title":"Osteoporosis in primary biliary cirrhosis revisited","volume":"49","author":"Newton","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.005_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/jhep.2001.22758","article-title":"Collagen type I\u03b11 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis","volume":"33","author":"Par\u00e9s","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1297-319X(02)00364-0","article-title":"Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease","volume":"69","author":"Le Gars","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cld.2008.02.005_bib22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/jhep.2002.36357","article-title":"Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry","volume":"36","author":"Guichelaar","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1590-8658(03)00078-1","article-title":"Osteoporosis: still a typical complication of primary biliary cirrosis?","volume":"35","author":"Solerio","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2008.02.005_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2036.2004.01890.x","article-title":"Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial","volume":"19","author":"Pereira","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2008.02.005_bib25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT; long-term follow-up and predictive factors","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2008.02.005_bib26","unstructured":"Par\u00e9s A, Cerd\u00e1 D, Monegal A, et\u00a0al. Factors associated with fracture prevalence and osteopenia in primary biliary cirrhosis. J Hepatol 2008, in press."},{"key":"10.1016\/j.cld.2008.02.005_bib27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0168-8278(00)80118-X","article-title":"Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial","volume":"33","author":"Lindor","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib28","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2006.09.012","article-title":"Fracture risk in people with primary biliary cirrhosis: a population-based cohort study","volume":"131","author":"Solaymani-Dodaran","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.005_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000171456","article-title":"Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management","volume":"12","author":"McCaughan","year":"1994","journal-title":"Dig Dis"},{"key":"10.1016\/j.cld.2008.02.005_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/8756-3282(93)90310-7","article-title":"Rates of cancellous bone remodelling and turnover in osteopenia associated with primary biliary cirrhosis","volume":"14","author":"Hodgson","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.cld.2008.02.005_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-8278(02)00435-X","article-title":"High serum osteoprotegerin and low RANKL in primary biliary cirrhosis","volume":"38","author":"Szalay","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib32","first-page":"463A","article-title":"High osteoprotegerin and low RANKL levels in\u00a0primary biliary cirrhosis. Relationship with the severity of liver disease but not with osteoporosis","volume":"40","author":"Par\u00e9s","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510280315","article-title":"Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis","volume":"28","author":"Gallego-Rojo","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0168-8278(98)80211-0","article-title":"Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment","volume":"28","author":"Cemborain","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib35","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2008.02.005_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jocd.2005.10.001","article-title":"Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease","volume":"9","author":"Smith","year":"2006","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.cld.2008.02.005_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.510310209","article-title":"Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"31","author":"\u00c2ngulo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib38","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archinte.166.12.1256","article-title":"Vitamin K and the prevention of fractures","volume":"166","author":"Cockayne","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cld.2008.02.005_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00774-004-0539-6","article-title":"Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG)","volume":"23","author":"Sasaki","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.cld.2008.02.005_bib40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI113125","article-title":"Genetic determinants of bone mass in adults; a twin study","volume":"80","author":"Pocock","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2008.02.005_bib41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJM198903023200903","article-title":"Reduced bone mass in daughters of women with osteoporosis","volume":"320","author":"Seeman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2008.02.005_bib42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/367284a0","article-title":"Prediction of bone density from vitamin D receptor alleles","volume":"367","author":"Morrison","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cld.2008.02.005_bib43","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jbmr.5650100622","article-title":"The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women","volume":"10","author":"Riggs","year":"1995","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.cld.2008.02.005_bib44","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jbmr.5650110908","article-title":"A large-scale population-based study of the association of vitamin D receptor gene polmorphisms with bone mineral density","volume":"11","author":"Uitterlinden","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cld.2008.02.005_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199707103370202","article-title":"Vitamin D-receptor gene polymorphisms and bone density in prepuberal American girls of Mexican descent","volume":"337","author":"Sainz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2008.02.005_bib46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1359\/jbmr.1997.12.2.234","article-title":"Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-America women","volume":"12","author":"McClure","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cld.2008.02.005_bib47","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jbmr.5650100621","article-title":"The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women","volume":"10","author":"Fleet","year":"1995","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.cld.2008.02.005_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng1096-203","article-title":"Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I\u03b11 gene","volume":"14","author":"Grant","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2008.02.005_bib49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199804093381502","article-title":"Relation of alleles of the collagen type I\u03b11 gene to bone density and the risk of osteoporotic fractures in postmenopausal women","volume":"338","author":"Uitterlinden","year":"1998","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.cld.2008.02.005_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00042737-200207000-00004","article-title":"Vitamin D receptor Bsm I, estrogen receptor alpha gene Pvu and Xba I and IL-1 receptor-antagonist gene VNRT polymorphism and bone mineral density in Hungarian patients with primary biliary cirrhosis","volume":"14","author":"Lakatos","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib52","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jbmr.5650110614","article-title":"Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cld.2008.02.005_bib53","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/jbmr.5650111203","article-title":"Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis","volume":"11","author":"Cooper","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cld.2008.02.005_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S8756-3282(03)00087-5","article-title":"Meta-analysis of COLIA1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture","volume":"32","author":"Mann","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.cld.2008.02.005_bib55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/01.meg.0000108364.41221.d0","article-title":"Insulin-like growth factor I (IGF-I) gene microsatellite repeat, collagen type I \u03b1I gene (COLIA1) Sp1 polymorphism and bone disease in primary biliary cirrhosis","volume":"16","author":"Lakatos","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib56","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","volume":"843","author":"Report of WHO Study Group","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.cld.2008.02.005_bib57","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","article-title":"AGA technical review on osteoporosis in hepatic disorders","volume":"125","author":"Leslie","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.005_bib58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","article-title":"Treatment of bone disorders in liver disease","volume":"45","author":"Pares","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib59","first-page":"191","article-title":"Effects ef active vitamin D3 metabolites on bone mineral metabolism ans plasma 1 alpha, 25-dihydroxyvitamin D levels in patients with liver cirrhosis: a cross-over study with alpha carcidol and calcitriol","volume":"23","author":"Kanda","year":"1995","journal-title":"Japanese Pharmacology & Therapeutics"},{"key":"10.1016\/j.cld.2008.02.005_bib60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1440-1746.1999.01913.x","article-title":"Calcitriol for bone disease in patients with cirrhosis of the liver","volume":"14","author":"Shiomi","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s005350050250","article-title":"Calcitriol for bone loss in patients with primary biliary cirrhosis","volume":"34","author":"Shiomi","year":"1999","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.005_bib62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0168-8278(92)90066-X","article-title":"Sodium fluoride prevents bone loss in primary biliary cirrhosis","volume":"15","author":"Gua\u00f1abens","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2008.02.005_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0016-5085(97)70098-2","article-title":"Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years","volume":"113","author":"Gua\u00f1abens","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.005_bib65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(97)80048-7","article-title":"Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled trial","volume":"26","author":"Wolfhagen","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib66","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis","volume":"98","author":"Gua\u00f1abens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.005_bib67","first-page":"S279","article-title":"Alendronate 70 mg once-weekly is more effective and has a better tolerability than alendronate 10 mg daily in the treatment of osteopenia associated with primary biliary cirrhosis","volume":"20","author":"Gua\u00f1abens","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cld.2008.02.005_bib68","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis: a randomised placebo-controlled trial","volume":"42","author":"Zein","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","article-title":"Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial","volume":"144","author":"Crawford","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2008.02.005_bib70","first-page":"47","article-title":"Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment","volume":"89","author":"Crippin","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.005_bib71","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1478-3231.1999.tb00034.x","article-title":"Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis","volume":"19","author":"Olsson","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.cld.2008.02.005_bib72","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1572-0241.2003.07341.x","article-title":"Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis","volume":"98","author":"Menon","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.005_bib73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2796.2004.01342.x","article-title":"An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis","volume":"256","author":"Ormarsdottir","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.cld.2008.02.005_bib74","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10620-006-8015-x","article-title":"Osteoporosis in primary biliary cirrhosis: a randomised trial of the efficacy and feasibility of estrogen\/progestin","volume":"51","author":"Boone","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2008.02.005_bib75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0168-8278(91)90941-4","article-title":"Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment","volume":"12","author":"Floreani","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.005_bib76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004836-199706000-00012","article-title":"A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis","volume":"24","author":"Floreani","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.005_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0270-9139(94)90098-1","article-title":"Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis","volume":"20","author":"Camisasca","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.005_bib78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","article-title":"Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study","volume":"25","author":"Levy","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2008.02.005_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2008.02.005_bib80","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.cld.2008.02.005_bib81","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","article-title":"Effect of recombinant human parathyroid hormone (1\u201384) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T12:01:13Z","timestamp":1588680073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326108000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1089326108000226"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2008.02.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}